This product is currently not available for purchase.


Therapeutic Enactment and Addiction. Edition No. 1

  • ID: 1898190
  • December 2009
  • 236 Pages
  • VDM Publishing House
1 of 3

While the literature is replete with studies that investigate Psychodrama as a method for working with individuals who suffer from the very serious problem of addiction, many are descriptive and do not employ a comprehensive theory of addiction to explain how or why this intervention might be effective. There is a dearth of research that systematically investigates what exactly changes in addicted clients as a result of psychodramatic intervention. This book links a particular formulation of Psychodrama (called Therapeutic Enactment) to the Adaptive Model of addiction (Alexander, 1990). Clients in 28-day residential treatment participated in Therapeutic Enactment as part of their program of recovery. Therapeutic Enactment sessions were videotaped and then observed by the co-investigator and participants. In-depth interviews were conducted after treatment intervention and again at three-month follow-up. Additional data sources included direct observations and documentation from client files. Qualitative data analysis revealed 16 reliable themes, the four most predominant being Self-Expression, Self-Awareness, Corrective Emotional Experience, and Change in Self-Schema.

Note: Product cover images may vary from those shown
2 of 3

James, Chan.
James Chan is a psychotherapist in the field of mental health. In addition to his professional background in business management, James holds a BA (Hons) from Simon Fraser University and a Master’s degree in Counselling Psychology from UBC. He has published articles,reports,and book chapters in the field of Mental Health and Addictions.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown



Our Clients

  • Procter & Gamble Co.
  • Western Union Company
  • Volvo Car Corporation
  • Morgan Stanley
  • SAP SE
  • LG Corporation
  • Roche Diagnostics Ltd.